Lindenstruth; Kai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lindenstruth; Kai.The latest application filed is for "pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists".

Company Profile

0.1.11

Lindenstruth; Kai - Loerrach DE
Lindenstruth; Kai - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (mglu5) Antagonists App 20170202819 - Chatterji; Ashish ; et al.	2017-07-20
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists App 20150140087 - Chatterji; Ashish ; et al.	2015-05-21
Pharmaceutical Composition For Treating Hcv Infections App 20130331314 - Leiminer; Andreas ; et al.	2013-12-12
New Solid Forms of [4-(3-Fluoro-5-Trifluoromethyl-Pyridin-2-Yl)-Piperazin-1-Yl-[5-Methanesul- fonyl-2-((S)-2,2,2-Trifluoro-1-Methyl-Ethoxy)-Phenyl]Methanone App 20130197225 - Bubendorf; Andre ; et al.	2013-08-01
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20120309969 - Bubendorf; Andre ; et al.	2012-12-06
Pharmaceutical Composition For Treating Hcv Infections App 20120114751 - Leiminer; Andreas ; et al.	2012-05-10
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (mglu5) Antagonists App 20120040008 - Chatterji; Ashish ; et al.	2012-02-16
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (mglu5) Antagonists App 20120039999 - Chatterji; Ashish ; et al.	2012-02-16
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20110295007 - Bubendorf; Andre ; et al.	2011-12-01
Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- fonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone Grant 8,039,473 - Bubendorf , et al. October 18, 2	2011-10-18
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20100311971 - Bubendorf; Andre ; et al.	2010-12-09
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20080214561 - Bubendorf; Andre ; et al.	2008-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.